Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy

3rd Auflage
ISBN: 978-0-443-27356-8
Verlag: Elsevier Science

Buch, Englisch, 848 Seiten, Format (B × H): 216 mm x 276 mm

Handbook of Brain Tumor Chemotherapy, Molecular Therapies, and Immunotherapy, Third Edition offers a unique cutting-edge collection of basic science and clinical information brain tumor chemotherapy research. The book represents the most complete single-volume resource available for information on the subject of brain tumor chemotherapy. Including a multidisciplinary approach, this volume combines recent advances tumor therapy with molecular biology, molecular therapeutics, immunobiology, and immunotherapy approaches in one location. Chapters new to this volume include cutting-edge research on the molecular underpinnings of brain tumors such as glioblastoma, other gliomas, and targeted molecular therapies to consider for treatment.

Autoren/Hrsg.

Newton, Herbert B

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Chemotherapie

Inhaltsverzeichnis

Section 1: PHARMACOLOGICAL AND CLINICAL APPLICATIONS
Section 2: INNOVATIVE CHEMOTHERAPY DELIVERY
Section 3: MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICS
Section 4: CHEMOTHERAPY SPECIFIC TUMORS - ADULTS
Section 5: CHEMOTHERAPY SPECIFIC TUMORS - PEDIATRICS
Section 6: IMMUNOTHERAPY FOR BRAIN TUMORS
Section 7: RESPONSE ASSESSMENT, QUALITY OF LIFE, NEUROPSYCHOLOGY, AND NEW FRONTIERS

Über Autor(innen)

Newton, Herbert B
Herbert B. Newton, M.D., FAAN, is currently the Medical Director for the Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center, in Cleveland, Ohio, where he is also a Professor of Neurology and Solid Tumor Oncology, and holds the William Burton Risman Neurological Institute Chair in Memory and Cognition. Prior to that he was the Director of the Neuro-Oncology Center and Medical Neuro-Oncology Program at the Advent Health Cancer Institute and Advent Health Orlando Campus in Orlando, Florida. He is also retired as a Professor of Neurology and Neurosurgery, Dardinger Neuro-Oncology Center, Esther Dardinger Endowed Chair in Neuro-Oncology and Division of Neuro-Oncology at the Ohio State University Medical Center and James Cancer Hospital, in Columbus, Ohio. He is a Diplomate of the American Board of Psychiatry and Neurology, a Fellow of the American Academy of Neurology and Royal Society of Medicine, and a member of numerous national and international societies.